ANXIETY DISORDER MONITORING

• US 20100280336A1
• Filed: 03/31/2010
• Published: 11/04/2010
• Est. Priority Date: 04/30/2009
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Stypulkowski, Paul H., Giftakis, Jonathon E., Rise, Mark T.
• Application Number:
  US12/751,537
• Publication Number:
  US 20100280336A1
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: A61B 5/1118 Determining activity level
• CPC Class Codes: A61B 5/165 Evaluating the state of mind, e.g. depression, anxiety
• CPC Class Codes: A61B 5/369 Electroencephalography [EEG] devices for psychotechnics A61B5/16
• CPC Class Codes: A61B 5/4803 Speech analysis specially adapted for diagnostic purposes
• CPC Class Codes: A61B 5/6846 specially adapted to be brought in contact with an internal body part, i.e. invasive
• CPC Class Codes: A61B 5/7267 involving training the classification device

Abstract

An anxiety episode may be identified as being an anxiety event that is attributable to an anxiety disorder of a patient based on the patient activity associated with the anxiety episode. The patient activity may include, for example, patient motion, patient posture or voice activity. Detection of the activity component during an anxiety episode can help distinguish between a general anxiety state and an anxiety event that differs from the general anxiety state. Examples of anxiety events include, for example, an occurrence of a compulsion or a panic attack. The detected anxiety events can be used to evaluate an anxiety disorder of a patient, evaluate therapy programs implemented by a medical device to treat the anxiety disorder, or control therapy delivery. In some examples, a mood state transition is detected based on patient activity information and therapy delivery is controlled based on the detection of the mood state transition.

Claims

1. A method comprising:

detecting, with a processor, an anxiety episode of a patient based on a physiological parameter of the patient; and

determining, with the processor, whether the anxiety episode is an anxiety event attributable to an anxiety disorder of the patient based on a signal indicative of patient activity.

2. The method of claim 1, wherein the signal is indicative of at least one of motion, posture state or voice activity of the patient.

3. The method of claim 1, wherein the anxiety disorder is characterized by the occurrence of a motor activity and determining whether the anxiety episode is the anxiety event comprises:

detecting, with the processor, the motor activity based on the signal; and

determining, with the processor, the anxiety episode is the anxiety event based on the detection of the motor activity.

4. The method of claim 3, wherein the motor activity comprises at least one of a compulsive motor activity, a motor tic, or at least one of a patient motion or posture state resulting from a compulsion.

5. The method of claim 1, wherein the anxiety disorder is characterized by the occurrence of a voice activity and determining whether the anxiety episode is the anxiety event comprises:

detecting, with the processor, the voice activity based on the signal; and

determining, with the processor, the anxiety episode is the anxiety event based on the detection of the voice activity.

6. The method of claim 5, wherein the voice activity comprises at least one of a compulsive act or a vocal tic.

7. The method of claim 1, wherein the signal comprises a first signal, and detecting the anxiety episode comprises:

receiving a second signal indicative of the physiological parameter; and

determining, with the processor, whether the second signal is indicative of the anxiety episode.

8. The method of claim 7, wherein determining whether the second signal is indicative of the anxiety episode comprises at least one of comparing a peak amplitude of the second signal to a threshold amplitude, comparing an average amplitude of the second signal to the threshold amplitude, comparing a median amplitude of the second signal to the threshold amplitude, comparing a trend in a waveform of the second signal over time to a template, comparing a power level within one or more frequency bands of the second signal to a threshold power level or comparing a ratio of power levels in two or more frequency bands of the second signal to a threshold power level ratio, and detecting the anxiety episode based on the comparison.

9. The method of claim 7, wherein the second signal is indicative of at least one of brain activity, a heart rate, respiratory rate, electrodermal activity, a facial expression or facial flushing of the patient.

10. The method of claim 7, wherein determining whether the second signal is indicative of the anxiety episode comprises determining whether the second signal is indicative of the anxiety episode with a support vector machine algorithm.

11. The method of claim 7, wherein determining whether the anxiety episode is an anxiety event attributable to an anxiety disorder of the patient based on the signal comprises:

temporally correlating the first and second signals; and

determining whether a portion of the first signal temporally correlated with the second signal is indicative of a predetermined patient activity.

12. The method of claim 7, further comprising determining a characteristic of the second signal indicative of the anxiety event at a first time, the method further comprising:

detecting the characteristic at a second time based on the second signal; and

adjusting therapy delivery to the patient upon detecting the characteristic.

13. The method of claim 1, further comprising adjusting therapy delivery to the patient upon determining the anxiety episode is the anxiety event attributable to the anxiety disorder.

14. The method of claim 1, further comprising generating a patient notification upon determining the anxiety episode is the anxiety event attributable to the anxiety disorder.

15. The method of claim 1, further comprising determining an anxiety metric associated with the anxiety episode, the anxiety metric comprising at least one of a duration of the anxiety episode, a latency between an anxiety episode onset and an onset of a patient activity indicative of the anxiety event, a classification of the latency, or a severity rating for the anxiety event.

16. The method of claim 1, further comprising:

at least one of determining a first amount of time the patient was in an anxiety episode during a selected time range, determining a second amount of time the patient was in an anxiety event during the selected time range, or determining a third amount of time the patient was an anxiety episode not attributable to the anxiety disorder; and

presenting the determined first, second or third amounts of times to a user via a user interface of a device.

17. The method of claim 1, further comprising:

associating the anxiety event with a therapy program implemented by a medical device at the time the anxiety event was detected, wherein the medical device delivers therapy to the patient according to therapy parameter values defined by the therapy program; and

ordering a list of therapy programs based on a number of associated anxiety events.

18. A method comprising:

receiving a first physiological signal indicative of an anxiety state of a patient;

receiving a second signal generated by a sensor, wherein the second signal is indicative of at least one of motion, posture state or voice activity of the patient; and

identifying, with a processor, an occurrence of an anxiety event during the anxiety state based on the first and second signals.

19. The method of claim 18, further comprising determining a characteristic of the first signal indicative of the anxiety event.

20. The method of claim 19, wherein the characteristic of the first signal indicative of the anxiety event prospectively indicates the anxiety event prior to occurrence of the anxiety event.

21. The method of claim 18, wherein identifying, with the processor, the occurrence of the anxiety event comprises:

detecting the anxiety state of the patient based on the first signal; and

during the anxiety state, detecting an activity component of the anxiety state based on the second signal, the activity comprising at least one of voice activity or motor activity.

22. A system comprising:

a first sensing module that generates a first signal indicative of physiological parameter of a patient;

a second sensing module that generates a second signal indicative of activity of the patient; and

a processor that detects an anxiety episode of the patient based on the first signal and determines whether the anxiety episode is an anxiety event attributable to an anxiety disorder of the patient based on the second signal.

23. The system of claim 22, wherein the second signal is indicative of at least one of motion, posture state or voice activity of the patient.

24. The system of claim 22, wherein the anxiety disorder is characterized by the occurrence a motor activity and the processor determines whether the anxiety episode is the anxiety event by at least detecting the motor activity based on the second signal and determining the anxiety episode is the anxiety event based on the detection of the motor activity.

25. The system of claim 24, wherein the motor activity comprises at least one of a compulsive motor activity, a motor tic, or at least one of a patient motion or posture state resulting from a compulsion.

26. The system of claim 22, wherein the anxiety disorder is characterized by the occurrence voice activity and the processor determines whether the anxiety episode is the anxiety event by at least detecting the voice activity based on the signal, and determining the anxiety episode is the anxiety event based on the detection of the voice activity.

27. The system of claim 22, wherein the processor determines whether the first signal is indicative of the anxiety episode by at least one of comparing a peak amplitude of the second signal to a threshold amplitude, comparing an average amplitude of the second signal to the threshold amplitude, comparing a median amplitude of the second signal to the threshold amplitude, comparing a trend in a waveform of the second signal over time to a template, comparing a power level within one or more frequency bands of the second signal to a threshold power level or comparing a ratio of power levels in two or more frequency bands of the second signal to a threshold power level ratio, and detecting the anxiety episode based on the comparison.

28. The system of claim 22, wherein the first signal comprises a bioelectrical brain signal or is indicative of at least one of a heart rate, respiratory rate, electrodermal activity, a facial expression or facial flushing of the patient.

29. The system of claim 22, wherein the processor implements a support vector machine algorithm to detect the anxiety episode based on the first signal.

30. The system of claim 22, wherein the processor detects an anxiety episode of the patient based on a first portion of the first signal and determines whether the anxiety episode is the anxiety event by at least temporally correlating the first and second signals and determining whether a second portion of the second signal temporally correlated with the first portion of the first signal is indicative of a predetermined patient activity.

31. The system of claim 22, wherein the processor determines a characteristic of the first signal indicative of the anxiety event.

32. The system of claim 31, further comprising a medical device, wherein the processor determines the characteristic of the first signal at a first time, detects the characteristic at a second time based on the first signal, and controls the medical device to adjust therapy delivery to the patient upon detecting the characteristic.

33. The system of claim 22, further comprising a medical device, wherein the processor controls the medical device to adjust therapy delivery to the patient upon determining the anxiety episode is the anxiety event attributable to the anxiety disorder.

34. The system of claim 22, wherein the processor generates a patient notification upon determining the anxiety episode is the anxiety event attributable to the anxiety disorder.

35. The system of claim 22, wherein the processor determines an anxiety metric associated with the anxiety episode, the anxiety metric comprising at least one of a duration of the anxiety episode, a latency between an anxiety episode onset and an onset of a patient activity indicative of the anxiety event, a classification of the latency, or a severity rating for the anxiety event.

36. The system of claim 22, further comprising a user interface, wherein the processor determines at least one of a first amount of time the patient was in an anxiety episode during a selected time range, a second amount of time the patient was in an anxiety event during the selected time range, or a third amount of time the patient was an anxiety episode not attributable to the anxiety disorder, and presents the determined first, second or third amounts of times to a user via the user interface.

37. The system of claim 22, further comprising a medical device, wherein the processor associates the anxiety event with a therapy program implemented by the medical device at the time the anxiety event was detected, wherein the medical device delivers therapy to the patient according to therapy parameter values defined by the therapy program and orders a list of therapy programs based on a number of associated anxiety events.

38. A system comprising:

a first sensing module that generates a first signal indicative of an anxiety episode of a patient;

a second sensing module that generates a second signal indicative of at least one of motion, posture state or voice activity of the patient; and

a processor that identifies an occurrence of an anxiety event based on the first and second signals.

39. The system of claim 38, wherein the processor determines the occurrence of the anxiety event by at least detecting the anxiety state of the patient based on the first signal, and, during the anxiety state, detecting an activity component of the anxiety state based on the second signal, the activity comprising at least one of voice activity or motor activity.

40. A system comprising:

means for generating a first signal indicative of a physiological parameter of a patient;

means for receiving a second signal generated by a patient activity sensor; and

means for determining whether a detected anxiety episode is an anxiety event attributable to an anxiety disorder of the patient based on the first and second signals.

41. The system of claim 40, wherein the second signal is indicative of at least one of motion, posture state or voice activity of the patient.

42. The system of claim 40, wherein the anxiety disorder is characterized by the occurrence a motor activity and the means for determining whether the detected anxiety episode is the anxiety event comprises:

means for detecting the motor activity based on the signal; and

means for determining the anxiety episode is the anxiety event based on the detection of the motor activity.

43. The system of claim 40, wherein the anxiety disorder is characterized by the occurrence voice activity and the means for determining whether the detected anxiety episode is the anxiety event comprises:

means for detecting the voice activity based on the signal; and

means for determining the anxiety episode is the anxiety event based on the detection of the voice activity.

44. A system comprising:

means for generating a first signal indicative of an anxiety state of a patient;

means for generating a second signal indicative of at least one of motion, posture state or voice activity of the patient; and

means for identifying an occurrence of an anxiety event during an anxiety state based on the first and second signals.

45. A computer-readable storage medium comprising instructions that cause a programmable processor to:

detect an anxiety episode of a patient based on a physiological parameter of the patient; and

determine whether the anxiety episode is an anxiety event attributable to an anxiety disorder of the patient based on a signal generated by a patient activity sensor.